A detailed history of Man Group PLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Man Group PLC holds 120,575 shares of RDY stock, worth $1.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
120,575
Previous 705,563 82.91%
Holding current value
$1.76 Million
Previous $51.8 Million 82.25%
% of portfolio
0.02%
Previous 0.14%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$68.26 - $76.19 $39.9 Million - $44.6 Million
-584,988 Reduced 82.91%
120,575 $9.19 Million
Q1 2024

May 15, 2024

SELL
$67.36 - $77.59 $4.02 Million - $4.63 Million
-59,630 Reduced 7.79%
705,563 $51.8 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $854,598 - $929,460
13,297 Added 1.77%
765,193 $53.2 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $36.9 Million - $43.4 Million
596,410 Added 383.58%
751,896 $50.3 Million
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $6.44 Million - $7.62 Million
120,753 Added 347.66%
155,486 $9.81 Million
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $321,017 - $360,556
-6,276 Reduced 15.3%
34,733 $1.8 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $4,990 - $5,732
-100 Reduced 0.24%
41,009 $2.15 Million
Q2 2022

Aug 15, 2022

SELL
$49.62 - $58.13 $253,062 - $296,463
-5,100 Reduced 11.04%
41,109 $2.28 Million
Q1 2022

May 16, 2022

BUY
$48.27 - $65.25 $381,333 - $515,475
7,900 Added 20.62%
46,209 $2.58 Million
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $136,850 - $154,675
-2,300 Reduced 5.66%
38,309 $2.51 Million
Q3 2021

Nov 15, 2021

SELL
$60.19 - $75.29 $18,057 - $22,587
-300 Reduced 0.73%
40,609 $2.65 Million
Q2 2021

Aug 16, 2021

SELL
$62.12 - $74.2 $421,856 - $503,892
-6,791 Reduced 14.24%
40,909 $3.01 Million
Q1 2021

May 17, 2021

BUY
$57.98 - $73.08 $127,556 - $160,776
2,200 Added 4.84%
47,700 $2.93 Million
Q4 2020

Feb 16, 2021

SELL
$62.61 - $71.29 $2.92 Million - $3.32 Million
-46,600 Reduced 50.6%
45,500 $3.24 Million
Q3 2020

Nov 16, 2020

SELL
$51.39 - $72.41 $2.79 Million - $3.94 Million
-54,376 Reduced 37.12%
92,100 $6.41 Million
Q2 2020

Aug 14, 2020

BUY
$39.55 - $54.65 $2.07 Million - $2.86 Million
52,300 Added 55.53%
146,476 $7.77 Million
Q1 2020

May 15, 2020

BUY
$34.75 - $45.85 $3.27 Million - $4.32 Million
94,176 New
94,176 $3.8 Million
Q1 2019

May 15, 2019

SELL
$35.77 - $40.57 $3.44 Million - $3.9 Million
-96,100 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$31.89 - $38.44 $3.06 Million - $3.69 Million
96,100 New
96,100 $3.62 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.42B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.